Advertisement

Reactions Weekly

, Volume 1765, Issue 1, pp 17–17 | Cite as

Adalimumab/infliximab/prednisone

Malignant transformation of underlying neurocutaneous melanosis to leptomeningeal melanoma: case report
Case report
  • 19 Downloads

Reference

  1. Schaff LR, et al. Malignant transformation of neurocutaneous melanosis (NCM) following immunosuppression. Pediatric Dermatology 36: 497-500, No. 4, Jul 2019. Available from: URL: http://doi.org/10.1111/pde.13804 - USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations